The place of hyperbaric oxygen therapy and ozone... (2017 study) Skip to main content
Retrospective Study Brazilian journal of otorhinolaryngology 2017

The place of hyperbaric oxygen therapy and ozone therapy in sudden hearing loss.

Ergun Taşdöven G, Derin AT, Yaprak N, Özçağlar HÜ, Brazilian journal of otorhinolaryngology, 2017

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers looked back at the records of 106 people with sudden hearing loss of unknown cause to compare three treatment groups: oral steroids alone, steroids plus hyperbaric oxygen therapy, and steroids plus ozone therapy.

What They Found

In this retrospective study of 106 patients with idiopathic sudden sensorineural hearing loss, response rates were 82.4 percent with steroids plus ozone, 61.5 percent with steroids plus hyperbaric oxygen, and 50.8 percent with steroids alone. The groups had 17, 26 and 65 patients. Steroids plus hyperbaric oxygen was not significantly different from steroids alone (p=0.355). Steroids plus ozone had a significantly higher response rate than steroids alone (p=0.019). Steroids plus hyperbaric oxygen and steroids plus ozone did not differ significantly (p=0.146). The abstract reports that steroid treatment was less effective in patients with severe hearing loss.

What This Means for Canadian Patients

For people with sudden hearing loss of unknown cause, this study found no significant difference in response between steroids alone and steroids plus hyperbaric oxygen. The abstract's closing statement says adding hyperbaric oxygen or ozone contributed to treatment success, but its own group comparison for hyperbaric oxygen did not reach significance, so the findings point in different directions. Anyone considering treatment should review these results with their own physician.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a retrospective comparison of patients who were not randomly assigned, and the hyperbaric oxygen and ozone groups were small (26 and 17 patients), so the differences between groups cannot be taken as proof that a treatment caused them.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 27460341
Year Published 2017
Journal Brazilian journal of otorhinolaryngology
MeSH Terms Adolescent; Adult; Aged; Aged, 80 and over; Audiometry; Combined Modality Therapy; Female; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Ozone; Retrospective Studies; Severity of Illness Index

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology